These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7508342)

  • 1. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus.
    Crook MA; Tutt P; Simpson H; Pickup JC
    Clin Chim Acta; 1993 Oct; 219(1-2):131-8. PubMed ID: 7508342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.
    Crook MA; Tutt P; Pickup JC
    Diabetes Care; 1993 Jan; 16(1):57-60. PubMed ID: 8422833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
    Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
    Yokoyama H; Jensen JS; Jensen T; Deckert T
    J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum levels of sialic acid in patients with type 1 diabetes mellitus in relation to the incidence of late complications].
    Spunda J; Neumann M; Bartásková D; Kvapil M
    Cas Lek Cesk; 1996 Nov; 135(22):723-5. PubMed ID: 8998824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum nickel levels of diabetic patients and healthy controls by AAS with a graphite furnace.
    Yarat A; Nokay S; Ipbüker A; Emekli N
    Biol Trace Elem Res; 1992 Dec; 35(3):273-80. PubMed ID: 1283693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
    Abdella N; Akanji AO; Mojiminiyi OA; Al Assoussi A; Moussa M
    Diabetes Res Clin Pract; 2000 Sep; 50(1):65-72. PubMed ID: 10936670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria.
    Crook MA; Earle K; Morocutti A; Yip J; Viberti G; Pickup JC
    Diabetes Care; 1994 Apr; 17(4):305-10. PubMed ID: 8026286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multivariate analysis for the understanding of typical diabetic hemostasis criteria. 3. Determination of a typical retinopathy parameter-constellation].
    Syrbe G; Schröder H; Keil E; Jütte A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):731-7. PubMed ID: 1709907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between serum sialic acid levels and retinopathy in Type 2 diabetic patients.
    Deepa R; Rema M; Mohan V
    Diabetes Res Clin Pract; 1998 Sep; 41(3):165-9. PubMed ID: 9829344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of blood protein levels between diabetic and non-diabetic patients with retinopathy.
    Gul A; Rahman MA
    J Coll Physicians Surg Pak; 2006 Jun; 16(6):408-11. PubMed ID: 16787618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.
    Nayak SB; Bhaktha G
    Lipids Health Dis; 2005 Aug; 4():15. PubMed ID: 16092968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus.
    Powrie JK; Watts GF; Crook MA; Ingham JN; Taub NA; Shaw KM
    Diabet Med; 1996 Mar; 13(3):238-42. PubMed ID: 8689844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
    Inayat-ur-Rahman ; Malik SA; Bashir M; Khan R; Iqbal M
    Phytomedicine; 2009 May; 16(5):401-5. PubMed ID: 19362455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum sialic acid with cardiovascular metabolic risk factors in Kuwaiti children and adolescents with type 1 diabetes.
    Moussa MA; Alsaeid M; Refai TM; Abdella N; Al-Sheikh N; Gomez JE
    Metabolism; 2004 May; 53(5):638-43. PubMed ID: 15131770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No difference in serum sialic acid in type 2 diabetic patients from the United Arab Emirates with and without diabetic retinopathy.
    Crook MA; Khandhadia S; Lumb P; Ridha A; Hussain A
    Diabetes Res Clin Pract; 2000 Feb; 47(2):147-50. PubMed ID: 10670915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urinary concentration of sialic acid is increased in non-insulin-dependent diabetic patients with microangiopathy: a possible useful marker for diabetic microangiopathy.
    Suzuki K; Ishida H; Sugimoto C; Taguchi Y; Matsuda H; Nosaka K; Someya Y; Kadowaki S; Seino Y
    Diabet Med; 1995 Dec; 12(12):1092-6. PubMed ID: 8750219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in glycosylated proteins in diabetic and non-diabetic patients with and without cardiovascular complications.
    Gul A; Rahman MA
    Asia Pac J Clin Nutr; 2003; 12(3):277-81. PubMed ID: 14505990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute phase serum proteins in diabetic retinopathy.
    Rema M; Mohan V; Snehalatha C
    Indian J Ophthalmol; 1996 Jun; 44(2):83-5. PubMed ID: 8916594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related (acute-phase) reaction.
    Pickup JC; Chusney GD; Mattock MB
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):107-12. PubMed ID: 10651761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.